We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Drones to Optimize Exchange of Samples between Hospitals

By LabMedica International staff writers
Posted on 18 Apr 2017
Print article
Image: A quadrocopter drone transporting a biological safety box (Photo courtesy of Swiss Post).
Image: A quadrocopter drone transporting a biological safety box (Photo courtesy of Swiss Post).
Switzerland is slated to become one of the first countries in the world to introduce the use of drones for routine transport of medical samples between hospitals.

A recent announcement stated that Swiss Post and the drone manufacturer Matternet would provide the infrastructure to transport samples between the Ticino EOC hospital group's Ospedale Italiano and the Ospedale Civico hospitals.

The drones to be used are compact quadrocopters that can carry up to two kilograms for up to 20 kilometers at an average speed of 36 kilometers per hour. Biological samples will be carried in a dedicated safety box, and the drones will be controlled with a smartphone application.

So far around 70 autonomous test flights have been conducted between the two hospital locations. The Swiss Federal Office for Civil Aviation (FOCA) has inspected the drone and its safety components, defined the legal conditions for flying it, and granted Swiss Post and Matternet approval for the flights. Further testing with flights is planned over a one-month period in summer 2017 and regular drone flights are expected to begin in 2018.

It is planned that drones will complement traditional parcel delivery sensibly, but they will not replace it.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

Renal cell carcinomas (RCCs) are notably diverse, encompassing over 20 distinct subtypes and generally categorized into clear cell and non-clear cell types; around 20% of all RCCs fall into the non-clear... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.